Plasma Expressor Machine Market Size

Plasma Expressor Machine Market size was over USD 109.2 million in 2023 and is projected to reach USD 170.78 million by 2036, growing at around 3.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of plasma expressor machine is evaluated at USD 112.26 million. Plasma expressor machine is a device used to separate plasma, RBC, WBC and platelets from the blood. Basically, it is used for easy and efficient blood component separation in any manner. Various diseases, such as, leukopenia or neutropenia require only the white blood cells, while dengue treatment requires platelets separately.  The growth of the market can be attributed to the growing need for any specific component of blood to treat various rare diseases. Blood cancer, such as, leukemia, lymphoma, and myeloma, are the primary disorders which entail the need for plasma expressor machines.

Moreover, the growing prevalence of blood cancer is estimated to boost the plasma expressor machine market growth. As per the data by the World Cancer Research Fund (WCRF), an estimated 18.1 million cancer cases were diagnosed around the world in 2020. Out of these, 18,094,716 new cancer cases were reported in 2020 itself. Among these, leukemia accounted for 474,519 cases, Hodgkin lymphoma accounted for 83,087 cases, and multiple myeloma accounted for 176,404 cases globally.